A study to assess how radium-223 moves through the patients with prostate cancer receiving radium-223 dichloride treatment.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506435-15-00

Acronym

20511

Enrollment

Registered

2024-02-21

Start date

2020-08-25

Completion date

2024-07-09

Last updated

2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

None listed

Sex/Gender

Male

Age

18 Years to No maximum

Austria, France, Italy, Lithuania

None listed

Source: EU CTIS · Data processed: Feb 4, 2026